Asciminib has 4 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Itraconazole Oral Solution Containing Hydroxypropyl-β-Cyclodextrin, Rosuvastatin, Itraconazole. Patients taking Asciminib should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Contraindicated
- 2
- Major
- 2
Contraindicated (2)
- Asciminib + Itraconazole Oral Solution Containing Hydroxypropyl-β-Cyclodextrin— Concomitant use decreases asciminib Cmax and AUC, which may reduce SCEMBLIX efficacy. Avoid coadministration at all reco…
- Asciminib + Rosuvastatin— Avoid concomitant use of SCEMBLIX at all recommended doses due to increased risk of rosuvastatin adverse reactions.
Major (2)
- Asciminib + Itraconazole— ( 7.1 ) Itraconazole Oral Solution Containing Hydroxypropyl-β-cyclodextrin: Avoid concomitant use of SCEMBLIX at all rec…
- Asciminib + Mao Inhibitors— Increases asciminib Cmax and AUC, which may increase risk of adverse reactions. Closely monitor during concomitant use a…